Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies

SIMPLE SUMMARY: Increasing evidence suggests that circulating cell-free DNA (cfDNA) testing might allow for monitoring the response to anti-EGFR monoclonal antibodies in patients with metastatic colorectal carcinoma (mCRC). However, few data are available in treatment-naïve patients. We tested cfDNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Rachiglio, Anna Maria, Forgione, Laura, Pasquale, Raffaella, Barone, Carlo Antonio, Maiello, Evaristo, Antonuzzo, Lorenzo, Cassata, Antonino, Tonini, Giuseppe, Bordonaro, Roberto, Rosati, Gerardo, Zaniboni, Alberto, Lonardi, Sara, Ferrari, Daris, Frassineti, Giovanni Luca, Tamberi, Stefano, Pisconti, Salvatore, Di Fabio, Francesca, Roma, Cristin, Orlandi, Armando, Latiano, Tiziana, Damato, Angela, Tortora, Giampaolo, Pinto, Carmine, Normanno, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870112/
https://www.ncbi.nlm.nih.gov/pubmed/35205799
http://dx.doi.org/10.3390/cancers14041052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870112/
https://www.ncbi.nlm.nih.gov/pubmed/35205799
http://dx.doi.org/10.3390/cancers14041052

Ejemplares similares